Treatment of autoimmune diseases with antagonists which bind to B cell surface markers
Details for Australian Patent Application No. 2005200462 (hide)
International Classifications
Event Publications
17 February 2005 Complete Application Filed
3 March 2005 Application Open to Public Inspection
Published as AU-A-2005200462
7 August 2008 Application Accepted
Published as AU-A-2005200462
4 December 2008 Standard Patent Sealed
15 January 2009 Corrigenda
Applications Accepted - Name Index Under the name Genentech, Inc. and IDEC Pharmaceuticals, Inc, Application No. 2005200462, under INID(71), correct the co applicant name to IDEC Pharmaceuticals, Inc.
5 July 2012 Application for Amendment
The nature of the amendment is: Amend the patentee name from Genentech, Inc. and IDEC Pharmaceuticals, Inc. to Genentech, Inc. and Biogen Idec Inc. . Address for service in Australia - Griffith Hack GPO Box 1285 Melbourne VIC 3001
25 October 2012 Alteration of Name
The name of the patentee has been altered to Genentech, Inc.; Biogen Idec Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser